SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $4,502,000 | +19.4% | 265,605 | 0.0% | 0.99% | +22.3% |
Q2 2018 | $3,772,000 | +28.5% | 265,605 | +72.0% | 0.81% | +26.9% |
Q1 2018 | $2,935,000 | +116.6% | 154,462 | +0.3% | 0.64% | +44.5% |
Q2 2017 | $1,355,000 | -58.9% | 154,000 | -71.7% | 0.44% | -82.6% |
Q1 2016 | $3,296,000 | – | 544,816 | – | 2.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
EMC Capital Management | 72,061 | $903,000 | 0.64% |
WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |